Giri Krishnamoorthy, Executive Vice President & Global Commercial Lead, brings more than 25 years of experience in commercial strategy, pre-commercialization, and strategic partnerships across vaccines and pharmaceuticals, spanning both global organizations and early-stage biotechnology companies.
Giri began his career in global clinical operations at SmithKline Beecham and Centocor before moving into business development at Johnson & Johnson and pre-commercialization at a JJDC start-up. He subsequently joined GSK, where he held a series of pre-commercial pediatric and adult vaccine leadership roles of increasing scope — including a secondment to the Office of the CEO and Future Strategy Group — and served as Global Commercial Lead for the Synflorix and Pneumococcal Vaccines Franchise and the UK Vaccines Business Unit. Most recently, he was at IQVIA as a Strategic Partnerships Lead, where he worked closely with emerging biotechnology companies, supporting their early- to late-stage development ambitions and governance across the R&D-to-commercial value chain.
He holds an MBA from Georgetown University.